Gagnon Securities LLC
- SEC CIK
- 0001125725
- Latest filing
- Aug 4, 2026
The latest 13F from Gagnon Securities LLC covers Q2 2026 (filed Aug 4, 2026): 83 long positions worth $518.8M. The top 10 holdings make up 47.7% of the portfolio, and the largest is CareDx, Inc. (CDNA) at 9.7%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 4
- Est. +$12.7M
- Added
- 25
- Est. +$45.2M
- Reduced
- 46
- Est. −$24.1M
- Sold out
- 6
- Est. −$31.1M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $518.8M
- +$85.6M (+19.8%) vs. prior quarter
- Positions
- 83
- −2 vs. prior quarter
- Top 10 concentration
- 47.7%
- Top 10 as share of value
- Turnover
- 11.6%
- Q2 2026, one quarter
- Average holding period
- 17.4 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $704.3M (Q2 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | 83 | $518.8M | CDNAWGSENSG | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 22, 2026 | 85 | $433.2M | ENSGCDNAAMRC | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 13, 2026 | 86 | $491.1M | CDNAWGSAL | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 3, 2025 | 86 | $498.5M | ALENSGWGS | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 23, 2025 | 87 | $492.4M | ALENSGCDNA | vs. Q1 2025 | SEC |
| Q1 2025 | May 9, 2025 | 98 | $454.5M | ALENSGISRG | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 24, 2025 | 91 | $496.3M | ALISRGCDNA | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 12, 2024 | 102 | $504.4M | CDNAENSGAL | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 97 | $444.0M | ALCDNAENSG | vs. Q1 2024 | SEC |
| Q1 2024 | May 13, 2024 | 98 | $422.5M | ALENSGCDNA | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 102 | $416.6M | ALENSGCDNA | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 97 | $399.1M | ALENSGISRG | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 8, 2023 | 97 | $480.9M | ALENSGISRG | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 10, 2023 | 112 | $475.8M | ALENSGNVGS | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 7, 2023 | 105 | $451.6M | ALENSGPCRX | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 101 | $454.8M | PCRXALENSG | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 1, 2022 | 101 | $477.1M | PCRXALENSG | vs. Q1 2022 | SEC |
| Q1 2022 | May 9, 2022 | 103 | $613.2M | PCRXALCDNA | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 8, 2022 | 104 | $666.7M | ALAOSLCDNA | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 12, 2021 | 112 | $673.1M | CDNAALPCRX | vs. Q2 2021 | SEC |
| Q2 2021 | Jul 28, 2021 | 111 | $704.3M | CDNAALENSG | vs. Q1 2021 | SEC |
| Q1 2021 | May 14, 2021 | 108 | $656.7M | CDNAALENSG | – | SEC |
13D and 13G filings
Companies where Gagnon Securities LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
7 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| PROFProfound Medical Corp. | 13G/A | 11.20%3.35M shares | – | Feb 9, 202110 filings | Jan 23, 2025 | SEC |
| TMCITreace Medical Concepts, Inc. | 13G/A | 9.60%6.14M shares | +3.30 ppfrom 6.30% | May 15, 20252 filings | Feb 12, 2026 | SEC |
| PSIXPower Solutions International, Inc. | 13G/A | 7.30%1.68M shares | 0.00 ppfrom 7.30% | Jan 23, 20252 filings | Jan 23, 2025 | SEC |
| CNFCNFinance Holdings Ltd. | 13G/A | 6.80%93.3M shares | 0.00 ppfrom 6.80% | Nov 14, 20252 filings | Feb 12, 2026 | SEC |
| OSUROrasure Technologies Inc | 13G | 5.80%8.87M shares | New | Aug 12, 20261 filing | Aug 12, 2026 | SEC |
| OSUROrasure Technologies Inc | 13G | 5.40%3.75M shares | +0.50 ppfrom 4.90% | Nov 17, 20253 filings | Apr 8, 2026 | SEC |
| AMRCAmeresco, Inc. | 13G | 5.00%1.76M shares | +0.10 ppfrom 4.90% | Oct 24, 20252 filings | Aug 27, 2026 | SEC |
Latest filings
36 filings on file made by Gagnon Securities LLC or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|---|
| AMRCAmeresco, Inc. | Aug 27, 20263:34 PM ET | Gagnon Securities LLCand 2 others | 13G | 5.00%1.76M shares | +0.10 ppfrom 4.90% | Aug 20, 2026 | SEC |
| OSUROrasure Technologies Inc | Aug 12, 20266:06 PM ET | Gagnon Securities LLCand 2 others | 13G | 5.80%8.87M shares | New | Aug 5, 2026 | SEC |
| CDNACareDx, Inc. | Aug 7, 20265:49 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 4.40%2.29M shares | −1.50 ppfrom 5.90%Below 5% | Jul 31, 2026 | SEC |
| OSUROrasure Technologies Inc | Apr 8, 20266:34 PM ET | Gagnon Securities LLCand 2 others | 13G | 5.40%3.75M shares | +0.50 ppfrom 4.90% | Jan 8, 2026 | SEC |
| TMCITreace Medical Concepts, Inc. | Feb 12, 20265:57 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 9.60%6.14M shares | +3.30 ppfrom 6.30% | Dec 31, 2025 | SEC |
| OSUROrasure Technologies Inc | Feb 12, 20265:56 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 4.90%3.57M shares | −0.10 ppfrom 5.00%Below 5% | Dec 31, 2025 | SEC |
| CNFCNFinance Holdings Ltd. | Feb 12, 20265:55 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 6.80%93.3M shares | 0.00 ppfrom 6.80% | Dec 31, 2025 | SEC |
| CDNACareDx, Inc. | Feb 12, 20265:54 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 5.90%3.05M shares | +0.70 ppfrom 5.20% | Dec 31, 2025 | SEC |
| OSUROrasure Technologies Inc | Nov 17, 20254:06 PM ET | Gagnon Securities LLCand 2 others | 13G | 5.00%3.59M shares | New | Nov 11, 2025 | SEC |
| CNFCNFinance Holdings Ltd. | Nov 14, 20253:42 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 6.80%93.3M shares | – | Sep 30, 2025 | SEC |
| AMRCAmeresco, Inc. | Oct 24, 20254:02 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 4.90%1.72M shares | –Below 5% | Sep 30, 2025 | SEC |
| CDNACareDx, Inc. | Jul 24, 20254:28 PM ET | Gagnon Securities LLCand 2 others | 13G | 5.20%2.89M shares | – | Jul 17, 2025 | SEC |
| TMCITreace Medical Concepts, Inc. | May 15, 20254:30 PM ET | Gagnon Securities LLCand 2 others | 13G | 6.30%3.98M shares | New | May 9, 2025 | SEC |
| CNFCNFinance Holdings Ltd. | Mar 12, 20259:23 PM ET | Gagnon Neiland 2 others | 13G | 5.10%70.4M shares | New | Feb 27, 2025 | SEC |
| AMRCAmeresco, Inc. | Mar 10, 20256:26 PM ET | Gagnon Neiland 2 others | 13G | 5.00%1.74M shares | – | Mar 3, 2025 | SEC |
| PSIXPower Solutions International, Inc. | Feb 14, 20251:17 PM ET | Gagnon Neiland 2 others | 13G/A | 5.00%1.14M shares | – | Feb 5, 2025 | SEC |
| PROFProfound Medical Corp. | Jan 23, 20256:38 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 11.20%3.35M shares | – | Dec 31, 2024 | SEC |
| PSIXPower Solutions International, Inc. | Jan 23, 20256:02 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 7.30%1.68M shares | 0.00 ppfrom 7.30% | Dec 31, 2024 | SEC |
| PSIXPower Solutions International, Inc. | Jan 23, 20256:02 PM ET | Gagnon Securities LLCand 2 others | 13G/A | 7.30%1.68M shares | – | Dec 31, 2024 | SEC |
| PROFProfound Medical Corp. | Nov 14, 2024 | Gagnon Securities LLC | 13G/AOld format | – | – | – | SEC |